ACH
CLDX icon

ArrowMark Colorado Holdings’s Celldex Therapeutics CLDX Stock Holding History

ArrowMark Colorado Holdings’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$793K Hold
25,000
– – 0.02% 251
2025
Q4 		$679K Hold
25,000
– – 0.01% 274
2025
Q3 		$647K Hold
25,000
– – 0.01% 267
2025
Q2 		$509K Hold
25,000
– – 0.01% 273
2025
Q1 		$454K Hold
25,000
– – 0.01% 274
2024
Q4 		$632K Hold
25,000
– – 0.01% 274
2024
Q3 		$850K Hold
25,000
– – 0.01% 255
2024
Q2 		$925K Hold
25,000
– – 0.01% 267
2024
Q1 		$1.05M Buy
+25,000
New +$1.03M 0.01% 265
2013
Q4 		– Sell
-3,635
Closed -$1.93M – 321
2013
Q3 		$1.93M Buy
3,635
+615
+20% +$211K 0.06% 186
2013
Q2 		$707K Buy
+3,020
New +$595K 0.19% 74

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return